Coloray International Investment Co., Ltd. (KOSDAQ:900310)
2,600.00
+130.00 (5.26%)
At close: May 14, 2026
KOSDAQ:900310 Revenue
In the year 2025, Coloray International Investment had annual revenue of 43.63B KRW with 0.02% growth. Coloray International Investment had revenue of 7.48B in the quarter ending December 31, 2025, a decrease of -43.37%.
Revenue
43.63B
Revenue Growth
+0.02%
P/S Ratio
0.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
33.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.63B | 7.76M | 0.02% |
| Dec 31, 2024 | 43.63B | -2.80B | -6.04% |
| Dec 31, 2023 | 46.43B | 7.57B | 19.48% |
| Dec 31, 2022 | 38.86B | -22.05B | -36.21% |
| Dec 31, 2021 | 60.91B | -12.83B | -17.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| System and Application Technologies | 166.42B |
| Wavus Co.,Ltd | 66.31B |
| Kyung Nam Pharm | 56.18B |
| T Scientific | 35.49B |
| NEORIGIN | 27.75B |
| MICUBE Solution | 24.01B |
| GFC Life Science | 18.26B |
| Finemedix | 9.86B |